1/12/2025Big Pharma Rushes to China for Deal Prospecting Despite Regulatory Unc...

1/11/2025China Rises to Become the Biopharma Innovation Source (Yang Report)

1/11/2025NMPA Holds the 2025 National Drug Supervision Work Conference

1/11/2025NHSA Issues Announcement on Revisions to Certain Drug Information in t...

1/11/2025NHSA Holds National Conference on Drug Pricing and Procurement

1/11/2025NHSA Issues the Interim Procedures for Managing BMI Payment Eligibilit...

1/11/2025CDE Issues the Technical Guidelines for Nonclinical Efficacy Studies o...

1/11/2025CDE Issues the Technical Guidelines for Clinical Trials of Anti-Monkey...

1/11/2025Merck's Gardasil 4 Receives New Indication Approval for Males in China

1/11/2025Suzhou Hemacell Biotech Secures Multi-Million CNY Investment to Advanc...

1/11/2025China Approves Combination Therapy of Padcev and Keytruda

1/11/2025Sanofi's Sarclisa (Isatuximab) Approved in China, Pioneering Use of Re...

1/7/2025Junshi Secures NMPA Approval for Toripalimab in 2nd-Line Melanoma Trea...

1/6/2025State Council Issues New Policy Document on Deepens Reform to Strength...

1/6/2025China Launches Action Plan to Tackle Dementia amid Aging Population Ch...

1/6/2025GSK's Nucala Gains Expanded Approval in China for CRSwNP Treatment

1/6/2025WuXi Bio Divests Irish Vaccine Facility to Merck Amid Potential U.S. R...

1/6/2025I-Mab Reprioritizes Pipeline and Halts CD73 Development

1/3/2025Biocon Wins NMPA Approval for Tacrolimus Capsules in China

1/3/2025China Punishes 40,000 in Medical Corruption Crackdown, Targeting Over ...

1/3/2025China Launches Mini-Programs to Boost Drug Price Transparency

1/3/2025China Strengthens Oversight of Medical Insurance Funds with Traceabili...

1/3/2025China Prioritizes Mental Health with Nationwide Initiative

1/3/2025WuXi Biologics and Sino Biopharm Partner on mAb Discovery

1/3/2025NMPA Issues Annexes for Pharmaceutical Excipients and Packaging Materi...

1/3/2025Astellas' Vyloy (zolbetuximab) Receives Marketing Approval in China fo...

1/3/2025Prime Gene Therapeutics Completes Over CNY 300M in Series B Financing

1/3/2025Platinum Life Receives Conditional Approval for China's First Stem Cel...

1/3/2025Recent Official and Executive Moves

1/2/2025Hutchmed Announces $608M Non-core Chinese Unit Stake Sale

Page:24/369 Total number of articles:11046: [First][<<] [22] [23] [24] [25] [26] [>>] [End]